A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.

Author: Blume-PeytaviUlrike, CanfieldDouglas, DietzEkkehart, Garcia BartelsNatalie, HillmannKathrin

Paper Details 
Original Abstract of the Article :
BACKGROUND: Although twice-daily application of propylene glycol-containing 2% minoxidil topical solution (MTS) stimulates new hair growth, higher concentrations of minoxidil in a once-daily, propylene glycol-free formulation may improve efficacy and reduce unpleasant side effects. OBJECTIVE: We so...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.jaad.2010.09.724

データ提供:米国国立医学図書館(NLM)

5% Minoxidil Foam vs. 2% Minoxidil Solution for Androgenetic Alopecia

This randomized, single-blind trial compares the efficacy and tolerability of 5% minoxidil topical foam (MTF) applied once daily to 2% minoxidil topical solution (MTS) applied twice daily in the treatment of androgenetic alopecia in women. The study aimed to determine whether a higher concentration of minoxidil in a once-daily, propylene glycol-free formulation could improve efficacy and reduce side effects. The study found that 5% MTF was non-inferior to 2% MTS in stimulating hair growth. 5% MTF also demonstrated several advantages, including greater improvements in hair count and width, improved overall efficacy, reduced local intolerance, and greater ease of use. This research provides valuable insights into the potential benefits of 5% MTF for the treatment of androgenetic alopecia in women.

5% Minoxidil Foam: A Promising Treatment for Androgenetic Alopecia

The study's findings suggest that 5% minoxidil foam may be a more effective and convenient treatment option for androgenetic alopecia in women compared to 2% minoxidil solution. The study's results support the use of 5% MTF as a safe and effective treatment for androgenetic alopecia, offering potential benefits in terms of efficacy, tolerability, and ease of use.

Navigating the Challenges of Hair Loss

The research highlights the importance of finding effective and convenient treatment options for androgenetic alopecia. The study's findings suggest that 5% MTF may offer a superior treatment experience for many women, potentially improving efficacy, reducing side effects, and enhancing ease of use. This research encourages further exploration of the potential benefits of 5% MTF as a treatment option for androgenetic alopecia.

Dr. Camel's Conclusion

Imagine a desert oasis, where a refreshing spring of hair growth flows freely. 5% minoxidil foam, like this oasis, offers a gentle and effective solution for women battling the challenges of androgenetic alopecia. This study reveals that 5% MTF, with its higher concentration and convenience, might be the preferred path to thicker, healthier hair.

Date :
  1. Date Completed 2011-12-30
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

21700360

DOI: Digital Object Identifier

10.1016/j.jaad.2010.09.724

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.